Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Zhang Z, Fan Z, Cao Y, Jia Z, Li G, Zhi X, et al
Hypoglycaemia : People with type 2 diabetes taking insulin or sulphonylureas alongside GLP-1-based therapies require careful monitoring due to an increased risk of hypoglycaemia
That includes looking at all the angles of GLP-1 drugs, including their potential side effects and how effective they are when used for treatment or prevention of diabetes, obesity and other conditions. Challenges for employers and employees 91% increase in PMPM costs between 12 months prior to starting a GLP-1 compared to 12 months after 9 The average cost of GLP-1 drugs can exceed $1,000 per patient per month
Inflammatory bowel disease and pancreatitis: a review
US$ 27.35
US$ 22.87
US$ 22.26
US$ 20.70
US$ 24.01
US$ 24.68
US$ 20.43
US$ 28.65
